Ignite Creation Date:
2025-12-25 @ 2:12 AM
Ignite Modification Date:
2025-12-26 @ 12:40 AM
Study NCT ID:
NCT00460460
Status:
TERMINATED
Last Update Posted:
2011-01-25
First Post:
2007-04-12
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Phase I, Open-label, Dose Escalation of AZD4877 in Hematologic Malignancies
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-03
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2007-08
Completion Date Type:
ACTUAL
First Submit Date:
2007-04-12
First Submit QC Date:
None
Study First Post Date:
2007-04-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-01-24
Last Update Post Date:
2011-01-25
Last Update Post Date Type:
ESTIMATED